Phreesia, Inc. (NYSE:PHR) Given Average Rating of “Hold” by Analysts

Shares of Phreesia, Inc. (NYSE:PHR) have received a consensus recommendation of “Hold” from the nineteen ratings firms that are covering the firm, MarketBeat reports. One analyst has rated the stock with a sell recommendation, ten have assigned a hold recommendation and eight have given a buy recommendation to the company. The average 1-year target price among brokerages that have covered the stock in the last year is $14.00.

PHR has been the topic of a number of research analyst reports. Robert W. Baird upped their target price on shares of Phreesia from $10.00 to $11.00 and gave the stock a “neutral” rating in a research note on Friday, September 4th. Weiss Ratings downgraded shares of Phreesia from a “sell (d+)” rating to a “sell (d)” rating in a research note on Friday, September 4th. Wall Street Zen lowered Phreesia from a “buy” rating to a “hold” rating in a report on Saturday, September 5th. DA Davidson dropped their price objective on Phreesia from $14.00 to $13.00 and set a “buy” rating on the stock in a research note on Friday, September 4th. Finally, Raymond James Financial downgraded Phreesia from an “outperform” rating to a “market perform” rating in a report on Tuesday, September 8th.

Hedge Funds Weigh In On Phreesia

Several institutional investors have recently made changes to their positions in PHR. EverSource Wealth Advisors LLC boosted its holdings in shares of Phreesia by 1,119.8% in the 1st quarter. EverSource Wealth Advisors LLC now owns 3,269 shares of the company’s stock valued at $27,000 after buying an additional 3,001 shares in the last quarter. New York State Teachers Retirement System bought a new position in shares of Phreesia during the 1st quarter worth approximately $44,000. Rockefeller Capital Management L.P. lifted its position in Phreesia by 354.6% during the fourth quarter. Rockefeller Capital Management L.P. now owns 2,755 shares of the company’s stock valued at $47,000 after acquiring an additional 2,149 shares during the last quarter. Allworth Financial LP purchased a new stake in Phreesia during the second quarter valued at approximately $58,000. Finally, Essential Partners LLC boosted its stake in Phreesia by 2,016.6% in the first quarter. Essential Partners LLC now owns 9,313 shares of the company’s stock valued at $78,000 after acquiring an additional 8,873 shares in the last quarter. Hedge funds and other institutional investors own 92.10% of the company’s stock.

Phreesia Stock Performance

PHR stock opened at $10.41 on Tuesday. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.33. The business’s fifty day simple moving average is $11.22 and its two-hundred day simple moving average is $10.39. Phreesia has a twelve month low of $7.77 and a twelve month high of $25.00. The firm has a market cap of $645.90 million, a price-to-earnings ratio of 61.22 and a beta of 0.86.

Phreesia (NYSE:PHR) last released its earnings results on Wednesday, September 2nd. The company reported $0.03 earnings per share for the quarter, missing the consensus estimate of $0.09 by ($0.06). The business had revenue of $129.46 million for the quarter, compared to the consensus estimate of $129.06 million. Phreesia had a return on equity of 5.22% and a net margin of 2.06%.The firm’s revenue for the quarter was up 10.4% compared to the same quarter last year. During the same quarter last year, the business posted $0.01 earnings per share. Analysts predict that Phreesia will post 0.33 earnings per share for the current year.

Phreesia Company Profile

Phreesia, Inc is a healthcare technology company that provides software and services designed to help healthcare organizations manage patient intake and engagement. Its platform digitizes administrative and clinical processes that traditionally rely on paper forms, manual data entry, and separate payment systems.

The company’s offerings include digital patient check-in and registration, insurance and demographic information collection, appointment-related communications, electronic forms and consent management, patient surveys, and payment processing.